Nanoform Finland Oyj (STO:NANOFS)

Market Cap	1.12B
Revenue (ttm)	41.96M
Net Income (ttm)	-268.44M
Shares Out	n/a
EPS (ttm)	-3.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,758
Average Volume	9,590
Open	13.02
Previous Close	12.90
Day's Range	12.86 - 13.06
52-Week Range	12.42 - 37.50
Beta	0.74
RSI	47.90
Earnings Date	Feb 27, 2025

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharmaceutical and biotech industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients, as well as designs and develops nanoformed drug substance. It also offers STARMAP, as a secure online portal to perform large numbers of in-silico CESS experiments The company was founded in 2008 and is headquarte...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 181
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: NANOFS

Financial Performance

In 2024, Nanoform Finland Oyj's revenue was 3.66 million, an increase of 42.70% compared to the previous year's 2.57 million. Losses were -23.43 million, 12.9% more than in 2023.

Financial numbers in EUR